LUNG CANCER RESEARCH
The granting of funds for research into the cure of lung cancer
Objects
TO PRESERVE AND PROTECT HEALTH BY PROMOTING AND FUNDING CLINICAL LABORATORY AND EPIDEMIOLOGICAL RESEARCH INTO THE CAUSES PREVENTION AND TREATMENT OF LUNG CANCER.
Financial health, per its FY2025 accounts
The accounts state that unrestricted funds decreased from £335,866 to £292,046 due to a net movement in funds of (43,820). Total incoming resources were £39,799, primarily from donations and legacies, while total resources expended were £83,619, largely for research funding at Imperial College. The independent examiner reported no matters coming to their attention regarding compliance with the Charities Act.
What the accounts disclose
“Legacies from estates Christine Bellamy 37,537”
Policies the charity declares
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Serious incident reporting policy and procedures
- Trustee conflicts of interest policy and procedures
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 31/12/2025
- Grant-making is its main activity
Self-declared on the annual return for the financial year ending 31/12/2024
- Grant-making is its main activity
Self-declared on the annual return for the financial year ending 31/12/2023
- Grant-making is its main activity
Annual return filing dates (Charity Commission record)
Of its last 3 annual returns with a recorded received date, 2 were received after the due date: year ending 31/12/2024 (received 23/04/2026, 174 days after the 31/10/2025 due date); year ending 31/12/2023 (received 21/04/2026, 537 days after the 31/10/2024 due date).
Trustees
- Alastair Stephen Meeks BA Honschair
- Nicola Anne Wyborn
- Professor Michael Julian Seckl PhD
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2025 | £40k | £84k |
| 31/12/2024 | £68k | £98k |
| 31/12/2023 | £9k | £115k |
Common questions
Is LUNG CANCER RESEARCH financially healthy?
Per its FY2025 accounts: The accounts state that unrestricted funds decreased from £335,866 to £292,046 due to a net movement in funds of (43,820). Total incoming resources were £39,799, primarily from donations and legacies, while total resources expended were £83,619, largely for research funding at Imperial College. The independent examiner reported no matters coming to their attention regarding compliance with the Charities Act. Its FY2025 accounts were independently examined.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| BREAST CANCER NOW | 1 | £300k |
| PHILIP KING CHARITABLE TRUST | 1 | £30k |
| DAVID LISTER CHARITABLE TRUST | 1 | £16k |
| PETER STORMONTH DARLING CHARITABLE TRUST | 1 | £13k |
| MISSES BARRIE CHARITABLE TRUST | 1 | £12k |
| THE INMAN CHARITY | 1 | £12k |
| THE AMELIA CHADWICK TRUST | 1 | £10k |
| THE CADOGAN CHARITY | 1 | £10k |
Charities like this
- EIG CANCER RESEARCH & SCHOLARSHIP FOUNDATION
- BREAST CANCER HOPE
- CURE CANCER @ UCL CANCER INSTITUTE
- BRAIN TUMOUR RESEARCH CAMPAIGN
- PROSTATE CANCER RESEARCH
- CANCER CARE HOSPITAL & RESEARCH CHARITABLE TRUST
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| LUNG CANCER RESEARCH | £40k | — | — | unclear | — | no doubt |
| EIG CANCER RESEARCH & SCHOLARSHIP FOUNDATION | £15k | — | 0 | unclear | — | no doubt |
| BREAST CANCER HOPE | £56k | — | 0 | unclear | — | no doubt |
| CURE CANCER @ UCL CANCER INSTITUTE | £39k | — | 0 | unclear | — | no doubt |
| BRAIN TUMOUR RESEARCH CAMPAIGN | £211k | — | 0 | unclear | — | no doubt |
| PROSTATE CANCER RESEARCH | £7.5m | £120,001 - £130,000 | — | unclear | 20.5% | no doubt |